Colon cancer test approved by FDA: At-home test yields 90 percent accuracy A new, noninvasive test may help physicians detect colorectal cancer earlier. The test has been approved by the FDA and is in the process of receiving Medicare approval. by Linda Nguyen
Healthy Living/Wellness FDA recommends Cologuard stool-based DNA test for colon cancer after it demonstrates 93.3 pct sensitivty by Rhodi Lee